+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer



A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer



Molecular Cancer Research 3(2): 110-118



alpha-Methylacyl-CoA racemase (AMACR), an enzyme involved in branched-chain fatty acid beta-oxidation that is normally expressed at high levels in human liver, is specifically and consistently overexpressed at both mRNA and protein levels in human prostate cancer and potentially other cancer types.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011696611

Download citation: RISBibTeXText

PMID: 15755877

DOI: 10.1158/1541-7786.mcr-04-0178


Related references

IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPalpha (CCAAT/enhancer-binding protein alpha)-stimulated expression of the sex-specific cytochrome P450 2C12 gene. Molecular Endocrinology 12(9): 1294-1309, 1998

Complexes containing activating transcription factor /cAMP-responsive-element-binding protein interact with the CCAAT/enhancer-binding protein -ATF composite site to regulate Gadd153 expression during the stress response. Biochemical Journal 339(1): 135-141, 1999

Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochemical Journal 339: 135-141, 1999

Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers. Molecular Biology of the Cell 9(6): 1479-1494, 1998

Temporal expression of the human alcohol dehydrogenase gene family during liver development correlates with differential promoter activation by hepatocyte nuclear factor 1 ccaat enhancer binding protein alpha liver activator protein and d element binding protein. Molecular & Cellular Biology 12(7): 3023-3031, 1992

HSF1 regulates expression of G-CSF through the binding element for NF-IL6/CCAAT enhancer binding protein beta. Molecular and Cellular Biochemistry 352(1-2): 11-17, 2011

A CCAAT/enhancer-binding protein site within antioxidant/electrophile response element along with CREB-binding protein participate in the negative regulation of rat GST-Ya gene in vascular smooth muscle cells. Journal of Biological Chemistry 275(35): 27366-27376, 2000

Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein beta in GH-stimulated c-fos expression. Journal of Endocrinology 196(1): 89-100, 2008

Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate. Prostate 68(11): 1206-1214, 2008

Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha. Molecular Endocrinology 17(8): 1522-1533, 2003

CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle. Journal of Virology 78(9): 4847-4865, 2004

Novel tumor necrosis factor-alpha responsive CCAAT/enhancer-binding protein site regulates cartilage Cd-rap expression. 2007

Heregulin and forskolin-induced cyclin D3 expression in Schwann cells: role of a CCAAT promoter element and CCAAT enhancer binding protein. Glia 45(3): 238-248, 2004

The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells. Molecular Endocrinology 20(5): 984-995, 2006

Regulation of hepatic six transmembrane epithelial antigen of prostate 4 (STEAP4) expression by STAT3 and CCAAT/enhancer-binding protein alpha. Journal of Biological Chemistry 285(22): 16453-16466, 2010